Cargando…
Point estimation following two‐stage adaptive threshold enrichment clinical trials
Recently, several study designs incorporating treatment effect assessment in biomarker‐based subpopulations have been proposed. Most statistical methodologies for such designs focus on the control of type I error rate and power. In this paper, we have developed point estimators for clinical trials t...
Autores principales: | Kimani, Peter K., Todd, Susan, Renfro, Lindsay A., Stallard, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175016/ https://www.ncbi.nlm.nih.gov/pubmed/29855066 http://dx.doi.org/10.1002/sim.7831 |
Ejemplares similares
-
Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection
por: Kimani, Peter K., et al.
Publicado: (2020) -
Estimation after subpopulation selection in adaptive seamless trials
por: Kimani, Peter K., et al.
Publicado: (2015) -
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility
por: Kimani, Peter K, et al.
Publicado: (2013) -
Estimation bias in survival data within clinical trials that use adaptive seamless designs
por: Khan, Josephine, et al.
Publicado: (2015) -
On the need to adjust for multiplicity in confirmatory clinical trials with master protocols
por: Stallard, N, et al.
Publicado: (2019)